Nalaganje...
Acute rosiglitazone treatment during reperfusion after hyperglycemic stroke is neuroprotective not vascular protective
Reperfusion therapy for ischemic stroke can cause secondary brain injury, especially under hyperglycemic (HG) conditions. Here we investigated the effect of acute treatment with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist, prior to postischemic reperfusion, on...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484888/ https://ncbi.nlm.nih.gov/pubmed/23125879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12975-012-0190-9 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|